Late outcomes after bone marrow transplant for aplastic anaemia
- 1 December 2000
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 111 (3) , 754-760
- https://doi.org/10.1111/j.1365-2141.2000.02452.x
Abstract
Allogeneic transplantation is effective in reconstituting haemopoiesis in severe aplastic anaemia (SAA). We report long‐term health‐related outcomes in 37 children and young adults with SAA transplanted between 1975 and 1996. The median length of follow‐up was 17 years (range, 4–25 years). Using a case–control design, late social and medical outcomes in transplant recipients were compared with 146 control subjects matched for gender and age. The majority of patients received an irradiation‐containing preparative regimen. There were no significant differences in the self‐rating of health status between transplant recipients and controls (P = 0·8), with 71% reporting their health status as excellent and 29% as good compared with 74% and 26% of controls. They demonstrate the same normal psychosexual function as their peers and have similar educational achievements and employment history. Transplant recipients and controls are equally likely to have held a job or be currently employed and there are no significant differences in their personal income (OR = 0·60, 95% CI = 0·11–3·37). Although transplant recipients have had problems related to health insurance policies, the majority have adequate health insurance coverage. There were no differences in chronic health problems between transplant recipients and control subjects, except for expected increases in cataracts, short stature in men, hypothyroidism and gonadal dysfunction. Using self‐assessment, these transplant recipients indicated an excellent level of satisfaction and social integration, showing transplantation to be an effective long‐term therapy for SAA.Keywords
This publication has 20 references indexed in Scilit:
- Validation of self-reported complications by bone marrow transplantation survivorsBone Marrow Transplantation, 2000
- Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapyTransplantation and Cellular Therapy, 1999
- Bone marrow transplantation for transfused patients with severe aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning therapy: long-term follow-up from a single centerBone Marrow Transplantation, 1999
- Long-Term Survival and Late Deaths after Allogeneic Bone Marrow TransplantationNew England Journal of Medicine, 1999
- Unrelated donor bone marrow transplantation for children and adolescents with aplastic anaemia or myelodysplasiaBritish Journal of Haematology, 1997
- Malignant Tumors Occurring after Treatment of Aplastic AnemiaNew England Journal of Medicine, 1993
- EXTENDED FOLLOW-UP IN 212 LONG-TERM ALLOGENEIC BONE MARROW TRANSPLANT SURVIVORS ISSUES OF QUALITY OF LIFETransplantation, 1993
- Treatment of Aplastic Anemia with Antilymphocyte Globulin and Methylprednisolone with or without CyclosporineNew England Journal of Medicine, 1991
- Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT* SAA Working PartyBritish Journal of Haematology, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958